State files lawsuit against one maker of OxyContin
November 02, 2017
“Alaska’s opioid crisis directly impacts people’s lives,” said Governor Bill Walker. “We have people becoming criminals to feed their habits. We have grandparents having to take care of grandchildren because the parents have fallen into the spiral of addiction or worse, have died from an over-dose. And the worst part is a lot of these people would have never become addicts without that initial prescription that went on too long.”
“We need to put a stop to these deceptive practices that are endangering people’s lives,” said Attorney General Lindemuth. “Pharmaceutical companies, like Purdue, need to be held accountable when they mislead providers and the public about how their drugs should be used.”
The Attorney General’s Office hired the firm Motley Rice on a contingency fee basis this summer to investigate whether any manufacturers or distributors of opioids had violated state consumer protection laws.
The investigation, as explained in the State’s lawsuit, uncovered that the majority of Medicaid spending on brand-name opioids was for OxyContin, the drug manufactured by Purdue. In fact, the top three prescribers of OxyContin in Alaska accounted for over $1 million in claims each between 2009 and 2017. Overall the investigation found that Purdue exhibited a pattern of deceptive marketing to convince practitioners to prescribe their drug. This included the use of seemingly neutral medical professionals and organizations who promoted the drug to their colleagues without disclosing their relationship to Purdue.
Although this complaint has been filed, the Alaska Attorney General’s Office continues to investigate whether additional claims should be brought against other manufacturers and distributors.
On the Web:
Editing by Mary Kauffman, SitNews
Source of News:
Representations of fact and opinions in comments posted are solely those of the individual posters and do not represent the opinions of Sitnews.